Soluble N-cadherin: A novel inhibitor of VSMC proliferation and intimal thickening
详细信息 查看全文
- 作者：Cressida A. Lyon ; Kerry S. Wadey ; Sarah J. George ; s.j.george@bristol.ac.uk" class="auth_mail" title="E-mail the corresponding author
- 关键词：Proliferation ; Intimal thickening ; Smooth muscle ; Endothelial ; Cadherin
- 刊名：Vascular Pharmacology
- 出版年：2016
- 出版时间：March 2016
- 年：2016
- 卷：78
- 期：Complete
- 页码：53-62
- 全文大小：1236 K
文摘
Reoccurrence of symptoms occurs in 30–50% of coronary artery disease patients receiving vein grafts or bare-metal stents due to intimal thickening (restenosis). Restenosis is caused by vascular smooth muscle cell (VSMC) migration and proliferation. New therapeutic approaches that reduce VSMC migration and proliferation while promoting endothelial cell (EC) coverage are required. We assessed the effect of a soluble form of N-cadherin (SNC-Fc, a fusion of the extracellular portion of N-Cadherin to a mutated Fc fragment of IgG), a cell–cell junction molecule, on human saphenous VSMC proliferation and migration in vitro. We also assessed its effect on intimal thickening in a validated human ex vivo organ culture model. We observed that SNC-Fc significantly inhibited VSMC proliferation and to a lesser extent migration. The anti-proliferative effect of SNC-Fc was mediated by the interaction of SNC-Fc with the FGFR, rather than through inhibition of β-catenin signalling. SNC-Fc also significantly reduced intimal thickening by ~ 85% in the ex vivo organ culture model. SNC-Fc treatment inhibited proliferation of the intimal cells but did not affect migration. SNC-Fc reduced EC apoptosis, without detrimental effects on EC proliferation and migration in vitro. Importantly SNC-Fc increased EC coverage in the ex vivo model of intimal thickening. In conclusion, we suggest that SNC-Fc may have potential as an anti-proliferative therapeutic agent for reducing restenosis which has no detrimental effects on endothelial cells.